Det får ingen konsekvenser at anvende NutropinAq til de godkendte indikationer, for hvilke benefit/ risk- forholdet forbliver uændret.
There are no consequences on the use of NutropinAq in the authorised indications, for which the balance of benefits and risks remains unchanged.